25 oktober 2005: Bron: Mark, Steven D., et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. Journal of the National Cancer Institute, Vol. 92, November 1, 2000, pp. 1753-63 [62 references]

Een studie toont aan dat een bepaalde seleniumwaarde in het bloed (200 microgram per dag wordt algemeen aangenomen als voldoende om deze waarde te bereiken), het aantal gevallen van slokdarmkanker en maagkanker ontstaan dicht bij het hart met 40 tot 50% kan doen afnemen. Dit blijkt uit een studie waarbij meer dan 590 slokdarmkankerpatiënten en 402 maagkankerpatiënten (kanker was ontstaan dicht bij het hart) zijn geanalyseerd en vergeleken met controlegroep van 1062 kankervrije personen. Hier het abstract van deze prospectieve studie.

Selenium in cancer prevention
BETHESDA, MARYLAND. Several large studies have found a clear association between low selenium levels and an increased risk of cancer. A major clinical trial involving supplementation with 200 micrograms/day of selenium (500 mg of high selenium brewer's yeast) was carried out in the United States in 1995. This trial concluded that selenium supplementation reduced overall cancer incidence by 40 per cent and cancer mortality by 50 per cent. Researchers from the National Cancer Institute and the Chinese Academy of Medical Sciences in Beijing now report that selenium deficient individuals are more likely to develop cancer of the esophagus and stomach than are individuals with adequate levels. Their study involved 590 patients with esophageal cancer, 402 with gastric cardia cancers (cancers located close to the junction between the esophagus and the stomach), and 87 with gastric non-cardia cancers as well as 1062 cancer-free control subjects. All participants had provided blood samples in 1985 prior to participating in the large Linxian study that investigated the benefits of various supplements in stomach cancer prevention. The researchers found that participants with blood serum levels of selenium at or above 90 micrograms/liter had a 44 per cent lower risk of developing esophageal cancer and a 53 per cent reduction in gastric cardia cancer risk when compared to participants with levels at or below 50 micrograms/liter. There was no correlation between selenium levels and the incidence of gastric non-cardia cancers. The researchers conclude that even individuals in the highest quartile (upper quarter) of selenium levels could benefit from selenium supplementation and that a supplement of 50 micrograms/day is not enough to correct a long-term deficiency. Mark, Steven D., et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. Journal of the National Cancer Institute, Vol. 92, November 1, 2000, pp. 1753-63 [62 references]

Plaats een reactie ...

Reageer op "Selenium hoog voorkomend in bloed voorkomt ontstaan van slokdarmkanker en maagkanker ontstaan dicht bij hart."


Gerelateerde artikelen
 

Gerelateerde artikelen

Selenium uit voeding kan eierstokkanker >> Selenium - Natrium seleniet >> Selenium - 5-methylselenocysteine >> Selenium voorkomt longkanker >> Selenium hoog voorkomend in >> Selenium: Wereld Kanker Onderzoek >> Selenium studie referenties >>